Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDP.TO
Strong BuyFull HouseMedexus Pharmaceuticals Inc. · Healthcare · Canada · $118M · Avg Vol: $182K/d
89
StockRankGet insider-trade alerts
Q
56
V
54
M
80
P/E (TTM)
—
ROE
-4.7%
D/E
0.5x
Dividend %
—
Loading 1Y...
PRICE (1Y)+0.4%
SMA 50SMA 200
Close
$3.66
RSI (14)
40.2
52W High
$3.98
From 52W High
0.9%
SCORE BREAKDOWN
Quality
56
ROIC
3.1%53.9
ROE
-4.7%42.0
GP/Assets
44.8%82.9
Op. Margin
7.4%59.6
FCF/Assets
2.5%58.7
Piotroski
377.2
Int. Cover
0.6x40.3
D/E Ratio
0.55x28.2
Current Ratio
1.30x20.1
Value
54
P/E (TTM)
—N/A
EV/EBITDA
7.8x78.4
P/FCF
31.7x42.7
P/B
1.7x67.1
P/S
1.1x81.0
Div Yield
—N/A
Momentum
80
52W High %
92%87.6
RS 6M
53%92.3
SMA 50/200
1.35x95.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+80%67.7
Q Growth
5%44.4
FUNDAMENTALS
Market Cap
$118M
P/E (Forward)
-253.0x
Gross Margin
63.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDP.TO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDP.TO | Medexus Pharmaceuticals Inc.(you) | $118M | 89 | Strong Buy |
| RX.V | BioSyent Inc. | $130M | 91 | Strong Buy |
| LOVE.TO | Cannara Biotech Inc. | $141M | 95 | Strong Buy |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 92 | Strong Buy |
| XLY.TO | Auxly Cannabis Group Inc. | $232M | 98 | Strong Buy |
| HLS.TO | HLS Therapeutics Inc. | $80M | 66 | Buy |
| OGI.TO | Organigram Global Inc. | $171M | 66 | Buy |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 44.2%